From November 1-3, Time Magazine convened leaders in medicine, government, business and public policy to discuss critical issues concerning global
The TB Alliance and the Korean Research Institute of Chemical Technology (KRICT) recently renewed their Agreement to develop novel quinolone
On November 2, 2005, at the Time Summit, Dr. Maria C. Freire, President & CEO of the TB Alliance participated
My pregnant 25-year-old patient was understandably concerned when her tuberculosis (TB) skin test came back positive. Her brother had died
PARIS–The amount of time required to treat tuberculosis (TB) could be halved if a series of phase II clinical trials
Bayer has signed an agreement with the Global Alliance for TB Drug Development to study whether the quinolone antibiotic, moxifloxacin,
Bayer Healthcare AG has signed an agreement with the Global Alliance for TB Drug Development to study whether the quinolone
Dr. Wafaa El-Sadr, who treats tuberculosis patients in central Harlem and in Durban, South Africa, believes that a new drug
The TB Alliance, a non-governmental drug development partnership, yesterday signed a pioneering agreement with Bayer, the German pharmaceutical group, that
